Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Hcallahan44on Oct 31, 2022 1:29pm
166 Views
Post# 35060608

RE:RE:RE:RE:Its that time of year again....

RE:RE:RE:RE:Its that time of year again....My case is simple....the market is not interested in this issue....despite all the pumping and projections on this board....institutional ownership is nil....the bottom line is Pela while it has some action....its nothing earth shaking....its not a cure for cancer....its just a tiny incremental improvement in treatment,...its probably worth something to someone but nowhere near the projections you have made.  I can tell you if i had pancreatic cancer....i would just want to die and get it over with...i wouldnt want to linger on for another month or two by taking this drug.  In the end you can say what you want....throw out all these detailed sciency sounding posts....but we sit at 1.20...ahead of a supposedly break through week.  The marked doesnt drink the same cool aid that you do....So Godot wont be coming next week if he comes at all.  I will any hype next week as an opportunity to exit and put the proceeds into Cassava Sciences....but i will be back next November to see the same BS pumping posts i have been reading for 5 years.....Amazing that Canada has been here for 20 and hasnt made a dime....Next time buy a CD buddy....
<< Previous
Bullboard Posts
Next >>